Coexpression of CD40 and CD40L on B Lymphoma and Carcinoma Cells: an Autocrine Anti-Apoptotic Role

Reference

• Sen, S. and D'Incalci, M. (1992) "Apoptosis. Biochemical events and relevance to cancer chemotherapy", FEBS Letter, 307, 122 — 127.
   Google Scholar
• Thompson, C.B. (1995) "Apoptosis in the pathogenesis and the treatment of disease", Science, 267, 1456–1462.
   Google Scholar
• Nicholson, D.W., Ali, A., Thornberry, N.A., Vaillancourt, J.P., Ding, C.K., Gallant, M., et al. (1995) "Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis", Nature, 376, 37.
   Google Scholar
• Datta, R., Banach, D., Kojima, H., Talanian, R.V., Alnemri, ES., Wong, W.W., et al. (1996) "Activation of the CPP32 protease in apoptosis induced by 1-b-D arabinofuranosyl cytosine and other DNA damaging agents", Blood, 88, 1936–1943.
   Google Scholar
• Del Bello, B., Valenti, MA., Zunino, F., Comporti, M. and Maellaro, E. (2001) "Cleavage of Bc1-2 in oxidant- and cisplatin-induced apoptosis of human melanoma cells", Oncogene, 20,4591 — 4595.
   Google Scholar
• Tan, G., Heqing, L., Jiangbo, C., Ming, J., Yanhong, M., Xianghe, L., et al. (2002) "Apoptosis induced by low-dose paclitaxel is associated with p53 upregulation in nasopharyngeal carcinoma cells", International Journal of Cancer, 97, 168 — 172.
   Google Scholar
• Miller, T.P., Chase, E.M., Dalton, W.S. and Grogan, T.M. (1997) The phenomenon of multidrug resistance in non Hodgkin's lymphoma. In Advances in Lymphoma Research, edited by F. Cabanillas and A. Rodriguez. Pp. 107–117. Boston. Kluwer Academic Publishers.
   Google Scholar
• Banchereau, J., Bazan, F., Blanchard, D., Briere, F., Galizzi, J.P., van Kooten, C., et al. (1994) "The CD40 antigen and its ligand", Annual Review of immunology, 12, 881 — 922.
   Google Scholar
• Voorzanger-Rousselot, N., Favrot, M.C. and Blay, J.Y. (1998) "Resistance to cytotoxic chemotherapy induced by CD40 ligand in lymphoma cells", Blood, 92, 338 1— 3387.
   Google Scholar
• Romano, M.F., Lamberti, A., Tassone, P., Alfinito, F., Costantini, S., Chiurazzi, F., et al. (1998) "Triggering of CD40 antigen inhibits fludarabine-induced apoptosis in B chronic leukemia cells", Blood, 92, 990–995.
   PubMed Web of Science ®Google Scholar
• Stamenkovic, I., Clark, E.A. and Seed, B. (1989) "A B lymphocyte activation molecule related to nerve growth factor receptor and induced by cytokines in carcinomas", EMBO Journal, 8, 1403 — 1410.
   Google Scholar
• Thomas, W.D., Smith, Mi., Si, Z. and Hersey, P. (1996) "Expression of the co-stimulatory molecules CD40 on melanoma cells", International Journal of Cancer, 68, 795–801.
   PubMed Web of Science ®Google Scholar
• Young, L.S., Eliopoulos, AG., Gallagher, N.J. and Dawson, C.W. (1998) "CD40 and epithelial cells: across the great divide", Immunology Today, 19, 502–506.
   PubMed Web of Science ®Google Scholar
• Voorzanger-Rousselot, N., Thomachot, MC., Alberti, L., Lefebvre, M.F. and Blay, J.Y. (2000). "CD4OL induces multidrug resistance to apoptosis in breast carcinoma and lymphoma cells through caspase dependent and independent pathways", Proc. Am. Assoc. Cancer Res., 41, 636 (Abstract 4047).
   Google Scholar
• Schattner, J., Elkon, KB., Yoo, D.H., Tumang, J., Krammer, PH., Crow, M.K., et al. (1995) "CD40 ligation induces Apo-1/Fas expression on human lymphocytes and facilitates apoptosis through the Apo-1/Fas pathway", Journal of Experimental Medicine, 182, 1557— 1565.
   Google Scholar
• Wang, H., Grand, R.J.A., Milner, A.E., Armitage, R.J., Gordon, J. and Gregory, C.D. (1996) "Repression of apoptosis in human B-lymphoma cells by CD40-ligand and Bc1-2: relationship to the cell-cycle and role of the retinoblastoma protein", Oncogene, 13, 373 — 379.
   Google Scholar
• Andersen, N.S., Larsen, J.K., Christiansen, J., Pedersen, LB., Christophersen, N.S., Geisler, C.H., et al. (2000) "Soluble CD40 ligand induces selective proliferation of lymphoma cells in primary mantle cell lymphoma cell cultures", Blood, 96, 2219–2225.
   PubMed Web of Science ®Google Scholar
• Funakoshi, S., Longo, D.L., Beckwith, M., Conley, D.K., Tsarfaty, G., Tsarfaty, I., etal. (1994) "Inhibition of human B-cell lymphoma growth by CD40 stimulation", Blood, 83, 2787–2794.
   PubMed Web of Science ®Google Scholar
• Francisco, J.A., Donaldson, K.L., Chace, D., Siegall, C.B. and Wahl, A.F. (2000) "Agonistic properties and in vivo antitumor activity of the anti-CD40 antibody SGN-14", Cancer Research, 60, 3225— 3231.
   Google Scholar
• Szocinski, J.L., Khaled, A.R., Hixon, J., Halverson, D., Funakoshi, S., Fanslow, W.C., et al. (2002) "Activation-induced cell death of aggressive histology lymphomas by CD40 stimulation: induction of bax", Blood, 100, 217–223.
   PubMed Web of Science ®Google Scholar
• Vonderheide, R.H., Dutcher, J.P., Anderson, J.E., Eckhardt, S.G., Stephans, K.F., Razvillas, B., et al. (2001) "Phase I study of recombinant human CD40 ligand in cancer patients", Journal of Clinical Oncology, 19, 3280–3287.
   PubMed Web of Science ®Google Scholar
• Younes, A. (2001) "CD40 ligand therapy of lymphoma patients", Journal of Clinical Oncology, 19, 4351 — 4353.
   Google Scholar
• Eliopoulos, AG., Dowson, C.W., Mosialos, G., Floettmann, J.E., Rowe, M., Armitage, R.J., et al. (1996) "CD40-induced growth inhibition in epithelial cells is mimicked by Epstein-Barr virus-encoded LMP-1: involvement of TRAF3 as a common mediator", Oncogene, 13, 2243–2254.
   PubMed Web of Science ®Google Scholar
• Hess, S. and Engelmann, H. (1996) "A novel function of CD40: induction of cell death in transformed cells", Journal of Experi-mental Medicine, 183, 159 — 167.
   Google Scholar
• Hirano, A., Longo, DL., Taub, D.D., Ferris, D.K., Young, L.S., Eliopoulos, AG., et al. (1999) "Inhibition of human breast carcinoma growth by a soluble recombinant human CD40 ligand", Blood, 93, 2999 — 3007.
   Google Scholar
• Papayoti, M.H., Tong, A.W., Banchereau, J. and Stone, M.J. (1998) "Induction of human breast carcinoma cell apoptosis by CD40-ligand", Proceedings of the National Academy of Sciences of the United States of America, 39, 582.
   Google Scholar
• Tong, A.W., Papayoti, M.H., Netto, G., Armstrong, D.T., Ordonez, G., Lawson, J.M., et al. (2001) "Growth-inhibitory effects of CD40 ligand (CD154) and its endogenous expression in human breast cancer", Clinical Cancer Research, 7, 691 —703.
   Google Scholar
• Younes, A., Snell, V., Consoli, U., Clodi, K., Zhao, SR., Palmer, J.L., et al. (1998) "Elevated levels of biologically active soluble CD40 ligand in the serum of patients with chronic lymphocytic leukemia", British Journal of Haematology, 100, 135–141.
   PubMed Web of Science ®Google Scholar
• Voorzanger, N., Touitou, R., Garcia, E., Delecluse, Hi., Rousset, F., Joab, I., et al. (1996) "Interleukin (IL)-10 and IL-6 are produced in vivo by non Hodgkin's lymphoma cells and act as cooperative growth factors", Cancer Research, 56, 5499 — 5505.
   Google Scholar
• Johnson, P.W., Watt, S.M., Betts, DR., Davies, D., Jordan, S., Norton, A.J., et al. (1993) "Isolated follicular lymphoma cells are resistant to apoptosis and can be grown in vitro in the CD40/ stromal cell system", Blood, 82, 1848— 1857.
   Google Scholar
• Clodi, K., Asgari, Z., Zhao, S., Kliche, K.O., Cabanillas, F., Andreeff, M., etal. (1998) "Coexpression of CD40 and CD40 ligand in B-cell lymphoma cells", British Journal of Haematology, 103, 270— 275.
   Google Scholar
• Clodi, K., Asgari, Z., Younes, M., Palmer, J.L., Cabanillas, F., Carbone, A., et al. (2002) "Expression of CD40 ligand (CD154) in B and T lymphocytes of Hodgkin disease: potential therapeutic significance", Cancer, 94, 1 — 5.
   Google Scholar
• Schattner, E.J., Mascarenhas, J., Reyfman, I., Koshy, M., Woo, C., Friedman, S.M., etal. (1998) "Chronic lymphocytic leukemia B cells can express CD40 ligand and demonstrate T-cell type costimulatory capacity", Blood, 91, 2689 — 2697.
   Google Scholar
• Romano, M.F., Lamberti, A., Turco, M.C. and Venuta, S. (2000) "CD40 and B chronic lymphocytic leukemia cell response to fludarabine: the influence of NF-KB/Rel transcription factors on chemotherapy-induced apoptosis", Leukemia and Lymphoma, 36, 255— 262.
   PubMed Web of Science ®Google Scholar